Variations in insurance coverage for autologous bone marrow transplantation for breast cancer
Erban, J.K.
New England Journal of Medicine 331(5): 330; Author Reply 330-331
1994
ISSN/ISBN: 0028-4793 PMID: 8022450 Document Number: 425356
Document emailed within 1 workday
Related Documents
Saez, R.A.; Selby, G.B.; Slease, R.B.; Epstein, R.B.; Mandanas, R.A.; Confer, D.L. 1994: Autologous bone marrow transplantation for metastatic breast cancer Journal of the Oklahoma State Medical Association 87(9): 405-410Peters, W.P.; Ross, M.; Vredenburgh, J.J.; Hussein, A.; Rubin, P.; Dukelow, K.; Cavanaugh, C.; Beauvais, R.; Kasprzak, S. 1994: The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer Seminars in Oncology 21(4 Suppl 7: 25-31
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Duhamel, G.; Gorin, N.C.; Douay, L.; Najman, A.; Stachowiak, J. 1982: Bone marrow repopulation after heavy chemotherapy and autologous bone marrow transplantation. Monitoring with biopsies and marrow culture on agar La Nouvelle Presse Medicale 11(11): 833-836
Gale, R.P.; Graze, P.R.; Wells, J.; Ho, W.; Hershko, C.; Lowenberg, B.; Feig, S.; Cline, M.J. 1979: Autologous bone marrow transplantation in patients with cancer Experimental Hematology 7(Suppl 5): 351-359
Schrøder, H.; Clausen, N.; Thorling, K.; Hokland, P. 1993: Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity Ugeskrift for Laeger 155(20): 1536-1539
Bolwell, B.J.; Fishleder, A.; Andresen, S.W.; Lichtin, A.E.; Koo, A.; Yanssens, T.; Burwell, R.; Baucco, P.; Green, R. 1993: G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment Bone Marrow Transplantation 12(6): 609-614
Oudshoorn, M.; Falkenburg, J.H.; Ebeling, L.J.; Haak, H.L.; Wijermans, P.W.; Fibbe, W.E.; Willemze, R.; van Rood, J.J. 1996: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft Bone Marrow Transplantation 18(2): 461-463
Chang, J.; Morgenstern, G.R.; Coutinho, L.H.; Scarffe, J.H.; Carr, T.; Deakin, D.P.; Testa, N.G.; Dexter, T.M. 1989: The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update Bone Marrow Transplantation 4(1): 5-9
Jackson, G.H.; Clarke, A.J.; Taylor, P.; Dickinson, A.M.; Proctor, S.J.; Cattan, A.R. 1991: Supernatant cell counts from long-term bone marrow culture correlate with the speed of engraftment following autologous bone marrow transplantation Bone Marrow Transplantation 8(6): 439-444
Gulati, S.; Acaba, L.; Yahalom, J.; Reich, L.; Motzer, R.; Crown, J.; Doherty, M.; Clarkson, B.; Berman, E.; Atzpodien, J. 1992: Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow Bone Marrow Transplantation 10(2): 129-134
Canals, C.; Picón, M.; Sanchez, T.; Torrico, C.; Amill, B.; Tugues, D.; Sierra, J.; Grañena, A.; Badell, I.; Brunet, S. 1994: Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging Progress in Clinical and Biological Research 389: 125-132
del Rosario Uriarte, M.; Bonomi, R.; Azambuja, C.; Seuánez, H.N. 1997: Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia Leukemia 11(12): 2213-2214
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016